Tadalafil Dosing Recommendations
For erectile dysfunction, start with tadalafil 10 mg taken as needed prior to sexual activity, or 2.5 mg once daily for continuous therapy; for pulmonary arterial hypertension, use 40 mg once daily. 1
Erectile Dysfunction Dosing
As-Needed Dosing
- Starting dose: 10 mg taken prior to anticipated sexual activity 1
- Titrate based on response: increase to 20 mg or decrease to 5 mg 1
- Maximum frequency: once per day in most patients 1
- Effective window: up to 36 hours following dosing 2, 1
The 2018 AUA Guideline strongly recommends dose titration to optimize efficacy 2. Dose titration is essential—work with patients to find the dose that meets treatment expectations without unacceptable adverse effects. 2 Research demonstrates dose-response effects for erectile function improvement 3.
Once-Daily Dosing
- Starting dose: 2.5 mg taken at approximately the same time daily 1
- May increase to 5 mg based on efficacy and tolerability 1
- No timing required relative to sexual activity 1
Once-daily dosing produces equivalent efficacy to on-demand dosing 2. Research shows both 5 mg and 10 mg once-daily regimens significantly improved erectile function, with 84.5-84.6% of patients reporting improved erections 4.
Pulmonary Arterial Hypertension Dosing
The FDA-approved and guideline-recommended dose is 40 mg once daily. 5, 6
The 2014 CHEST Guideline explicitly states: "Treatment with more than the recommended dose of tadalafil (40 mg once daily) has not been studied and is not recommended." 5 The pivotal trial demonstrated that 40 mg significantly improved 6-minute walk distance (33 m placebo-corrected), time to clinical worsening, and quality of life 7. Long-term data supports sustained efficacy at this dose 8.
Pediatric PAH Dosing
- Starting dose: 0.5-1 mg/kg/day orally 9
- Maximum dose: 40 mg daily 9
- Evaluated only in children >3 years of age 9
- Safety and efficacy data in children are limited 9
Dose Adjustments for Organ Impairment
Renal Impairment
As-Needed Dosing:
- CrCl 30-50 mL/min: Start with 5 mg, maximum 10 mg once every 48 hours 1
- CrCl <30 mL/min or hemodialysis: Maximum 5 mg once every 72 hours 1
Once-Daily Dosing:
- CrCl <30 mL/min or hemodialysis: Not recommended for erectile dysfunction 1
- CrCl 30-50 mL/min (for BPH/ED): Start with 2.5 mg, may increase to 5 mg 1
The 2018 AUA Guideline advises using PDE5 inhibitors with caution at lower initial doses in renal impairment due to delayed metabolism 2. Research confirms renal insufficiency results in approximately twice the systemic exposure 10.
Hepatic Impairment
As-Needed Dosing:
- Mild-moderate (Child-Pugh A or B): Maximum 10 mg once per day 1
- Severe (Child-Pugh C): Not recommended 1
Once-Daily Dosing:
The AUA Guideline states PDE5 inhibitors are generally not recommended in severe renal or liver disease 2. Research shows hepatic impairment has negligible effects on tadalafil exposure, but caution remains warranted 10.
Critical Prescribing Considerations
Contraindications
- Absolute contraindication: Concurrent nitrate use in any form 1, 11
- Risk of severe hypotension when combined with nitrates 11
Drug Interactions
- Alpha-blockers: Patients must be stable on alpha-blocker therapy before initiating tadalafil at the lowest dose 1
- CYP3A4 inhibitors (diltiazem, verapamil): Exercise caution due to increased hypotension risk 11
- Riociguat: Do not use PDE5 inhibitors for erectile dysfunction in patients on riociguat for PAH due to systemic hypotension risk 5
Patient Education
Incorrect use accounts for a large percentage of treatment failures. 2 Instruct patients that:
- Sexual stimulation is necessary for erectile dysfunction treatment 2
- More than one trial may be required to establish efficacy 2
- Medication can be taken without regard to food 1
- Large meals may reduce effectiveness 2
Combination Therapy
For erectile dysfunction with testosterone deficiency, tadalafil combined with testosterone therapy is more effective than tadalafil alone 2. However, testosterone is not effective as monotherapy for erectile dysfunction 2.
Common Adverse Effects
Most frequent: headache, dyspepsia, back pain, nasal congestion, myalgia, flushing 2. Tadalafil has the lowest rates of flushing among PDE5 inhibitors 2. Adverse events follow a dose-response pattern 2.